VFM
FLGT icon

Vivid Financial Management’s Fulgent Genetics FLGT Stock Holding History

Vivid Financial Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$299K Sell
2,969
-1,581
-35% -$139K 0.11% 101
2021
Q3 		$409K Sell
4,550
-750
-14% -$68.2K 0.17% 80
2021
Q2 		$489K Sell
5,300
-65
-1% -$5.19K 0.2% 72
2021
Q1 		$518K Sell
5,365
-2,632
-33% -$272K 0.24% 59
2020
Q4 		$417K Buy
+7,997
New +$334K 0.2% 81

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vivid Financial Management's FLGT Position: Q4 2021 in Review

Vivid Financial Management reduced its Fulgent Genetics (FLGT) stake by 35% in Q4 2021, selling an estimated $139K and leaving 2,969 shares worth $299K. The position accounts for 0.11% of the portfolio, ranked #101.

Vivid Financial Management first reported a position in FLGT in Q4 2020 and has held it in 5 quarters since. The position peaked at $518K in Q1 2021. 299 funds tracked by Wall St. Rank hold FLGT as of Q4 2021.

  • Vivid Financial Management held 2,969 shares of Fulgent Genetics worth $299K as of Q4 2021.
  • Vivid Financial Management sold 1,581 Fulgent Genetics shares in Q4 2021, an estimated $139K.
  • Fulgent Genetics made up 0.11% of Vivid Financial Management's portfolio in Q4 2021, its #101 holding.
  • Vivid Financial Management first reported a position in Fulgent Genetics in Q4 2020 and has held it in 5 quarters since.
  • Vivid Financial Management's Fulgent Genetics position peaked at $518K in Q1 2021.
  • 299 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2021.

Based on Vivid Financial Management's 13F filing for Q4 2021, filed 21 Jan 2022.